Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shuangyang Houbitong Granules for Pediatric Acute Pharyngitis/Tonsillitis (Wind-Heat Pattern)
CTR20244639Phase 2Suspended
- Sponsor
- Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Start
- Dec 2024
- Countries
- 1
01
Overview
A Phase 2 trial of Shuangyang Houbitong in acute pharyngitis, acute tonsillitis, sponsored by Guizhou Bailing Group Pharmaceutical Co., Ltd.. Started Dec 2024; status: suspended.
02
Drugs
Shuangyang Houbitong
03
Conditions
acute pharyngitisacute tonsillitis
Beyond the preview
Go deeper on CTR20244639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20244639.